• Premier Health Group (PHGI) has announced the launch of its direct-to-consumer telemedicine app, CloudMD
  • The app connects patients to doctors in real-time via video conferencing
  • CloudMD will initially be launched to over 5 million patients in British Columbia
  • Premier Health shares are currently up 4.88 per cent to C$0.43, with a market cap of C$34.73 million

Premier Health Group (PHGI) has announced the launch of its direct-to-consumer CloudMD app.

CloudMD works by connecting patients to physicians for a real-time consultation via on-demand video conferencing, and the app can be accessed using a smartphone, tablet or computer.

“We are excited to be launching our telemedicine service directly to consumers, enabling quality access to care for patients throughout British Columbia,” said Premier Health CEO, Dr. Essam Hamza.

“Telemedicine prevents lapses in medical care and costly visits to the emergency department, enables team-based care across different health care providers and saves travel costs and inconveniences to patients.”

CloudMD will be initially launched to over 5 million patients in the British Columbia area, and the service will be available beyond clinical hours, including the weekends.

With electronic charts created for each individual patient, health care providers will quickly be able to understand their past and current health statuses, enabling more efficient care.

“With the latest Coronavirus outbreak, heading to a doctor’s office or emergency room not only increases demand on already stretched resources, but also increases your chances of exposure,” Dr. Hamza continued.

“A telemedicine visit can be used effectively to get timely needed care and to reduce the spread of infection. Being at the forefront of today’s dynamic healthcare environment, we are paving the way to connect patients with the care they need when they need it.” 

Premier Health shares are currently up 4.88 per cent to C$0.43, with a market cap of C$34.73 million.

More From The Market Online

Voyageur Pharmaceuticals signs $2.6M contract in Latin America

Voyageur Pharmaceuticals (TSXV:VM) announces its first international distribution agreement with a C$2.6 million commitment.
BriaCell Therapeutics Corp

BriaCell to report positive cancer research at medical convention

BriaCell Therapeutics (TSX:BCT) will present positive clinical data of Bria-IMT at the 2024 American Society of Clinical Oncology in Chicago.

Cloud DX among leading remote patient monitoring suppliers in Canada

Cloud DX (TSXV:CDX) gives an update on its remote patient monitoring deal with the British Columbia Provincial Health Services Authority.